Literature DB >> 34942327

Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies.

Hui Li1, Yao Zhang2, Hong Shu2, Wenhao Lv2, Chunhong Su2, Fang Nie3.   

Abstract

Ultrasound is one of the safest and most advanced medical imaging technologies that is widely used in clinical practice. Ultrasound microbubbles, traditionally used for contrast-enhanced imaging, are increasingly applied in Ultrasound-targeted Microbubble Destruction (UTMD) technology which enhances tissue and cell membrane permeability through cavitation and sonoporation, to result in a promising therapeutic gene/drug delivery strategy. Here, we review recent developments in the application of UTMD-mediated gene and drug delivery in the diagnosis and treatment of tumors, including the concept, mechanism of action, clinical application status, and advantages of UTMD. Furthermore, the future perspectives that should be paid more attention to in this field are prospected.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer treatment; Drug /Gene delivery; Micro/nanotechnology; Sonoporation; Ultrasound

Mesh:

Substances:

Year:  2021        PMID: 34942327     DOI: 10.1016/j.ijpharm.2021.121412

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.

Authors:  Zhilin Li; Xiaoqin Lai; Shiqin Fu; Long Ren; Hao Cai; Hu Zhang; Zhongwei Gu; Xuelei Ma; Kui Luo
Journal:  Adv Sci (Weinh)       Date:  2022-06-02       Impact factor: 17.521

2.  Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.

Authors:  Yezi Chen; Xiaoqin Luo; Yun Liu; Yunlei Zou; Shiqi Yang; Chaoqi Liu; Yun Zhao
Journal:  Int J Nanomedicine       Date:  2022-09-07

3.  Exploring the relationship between autophagy and Gefitinib resistance in NSCLC by silencing PDLIM5 using ultrasound-targeted microbubble destruction technology.

Authors:  Yao Zhang; Wenhao Lv; Hui Li; Tiantian Dong; Hao Wu; Chunhong Su; Hong Shu; Fang Nie
Journal:  Cancer Cell Int       Date:  2022-09-25       Impact factor: 6.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.